Mycoplasma pneumoniae-Triggered Guillain-Barré Syndrome in Children: Two Case Reports of Different ICU Presentations

Sajjad M AlKadhem1, Alzahra Alradhi2, Hadeel A AlJubab3

  • 1Pediatrics Intensive Care, King Fahad Medical City, Riyadh, SAU.

Cureus
|December 27, 2024
PubMed

Insights

Mycoplasma pneumoniae can trigger Guillain-Barré syndrome (GBS) in children, presenting atypically. Prompt diagnosis and treatment are crucial for pediatric GBS cases.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Pediatrics

Background:

  • Guillain-Barré syndrome (GBS) is an acute immune-mediated polyneuropathy.
  • Mycoplasma pneumoniae is an emerging trigger for GBS, especially in pediatric populations.

Observation:

  • This report details two pediatric intensive care unit cases of atypical Mycoplasma pneumoniae-associated GBS.
  • Case 1: A 10-year-old boy with pharyngeal-cervical-brachial variant GBS, experiencing descending paralysis requiring mechanical ventilation and tracheostomy.
  • Case 2: A 2-year-old boy with ascending GBS, complicated by sickle cell anemia.

Findings:

  • Both pediatric cases demonstrated a clear link between Mycoplasma pneumoniae infection and Guillain-Barré syndrome.
  • Atypical presentations of GBS in children necessitate vigilant diagnostic approaches.

Implications:

  • These cases highlight the importance of considering Mycoplasma pneumoniae in pediatric GBS, even with unusual clinical courses.
  • Early recognition and aggressive management are vital for improving outcomes in pediatric Guillain-Barré syndrome.
  • Further research into the specific mechanisms of M. pneumoniae-induced GBS in children is warranted.